Diagnosing Comorbid Psychiatric Disorders in Substance Abusers: Validity of the Spanish Versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV

Torrens, Marta; Serrano, Domènec; Astals, M.; Pérez-Domínguez, Gustavo; Martín‐Santos, Rocío

doi:10.1176/appi.ajp.161.7.1231

Cited by 197 publications

(181 citation statements)

References 28 publications

Supporting

Mentioning

167

Contrasting

Unclassified

Order By: Relevance

“…2.2.1 Diagnoses: DSM-IV diagnoses were made using the PRISM-IV (Hasin et al, 1996), the best instrument currently available to reliably differentiate between substance-induced and other psychotic disorders (kappa 0.70-0.83; Torrens et al, 2004). The researchers were trained in the use of the PRISM by LH, an accredited user.…”

Section: Methodsmentioning

confidence: 99%

The profile of psychiatric symptoms exacerbated by methamphetamine use

McKetin

Dawe

Burns

et al. 2016

Drug and Alcohol Dependence

View full text Add to dashboard Cite

Methods: 164 methamphetamine users, who did not meet DSM-IV criteria for a lifetime primary psychotic disorder, were followed monthly for one year to assess the relationship between days of methamphetamine use and symptom severity on the 24-item Brief Psychiatric Rating Scale.Exacerbation of psychiatric symptoms with methamphetamine use was quantified using random coefficient models. The dimensions of symptom exacerbation were examined using principal axis factoring and a latent profile analysis. Results:Symptoms exacerbated by methamphetamine loaded on three factors: positive psychotic symptoms (suspiciousness, unusual thought content, hallucinations, bizarre behavior); affective symptoms (depression, suicidality, guilt, hostility, somatic concern, self-neglect); and psychomotor symptoms (tension, excitement, distractibility, motor hyperactivity). Methamphetamine use did not significantly increase negative symptoms. Vulnerability to positive psychotic and affective symptom exacerbation was shared by 28% of participants, and this vulnerability aligned with a past year DSM-IV diagnosis of substance-induced psychosis (38% vs. 22%, χ 2 (df 1) = 3.66, p = 0.056). Conclusion:Methamphetamine use produced a symptom profile comprised of positive psychotic and affective symptoms, which aligned with a diagnosis of substance-induced psychosis, with no evidence of a negative syndrome.

show abstract

Section: Methodsmentioning

confidence: 99%

The profile of psychiatric symptoms exacerbated by methamphetamine use

McKetin

Dawe

Burns

et al. 2016

Drug and Alcohol Dependence

View full text Add to dashboard Cite

show abstract

“…In addition to socio-demographic and consumption variables, the Spanish Version of the Psychiatric Research Interview for Substance and Mental Disorders (PRISM) (Torrens et al, 2004;Hasin et al, 1996) was administered. This interview, based on DSM-IV, diagnoses approximately 20 Axis I and II disorders.…”

Section: Assessments and Measuresmentioning

confidence: 99%

Clinical differences between cocaine-induced psychotic disorder and psychotic symptoms in cocaine-dependent patients

Roncero

Comín

Daigre

et al. 2014

Psychiatry Research

Self Cite

View full text Add to dashboard Cite

Page 2 of 24The aim of this study is to compare the clinical characteristics of three groups of patients in treatment for cocaine dependence: patients without any psychotic symptoms (NS), patients with transient psychotic symptoms (PS) and patients with cocaine-induced psychotic disorder (CIPD). An observational and retrospective study of 150 cocaine-dependent patients undergoing treatment in the Drug Unit of the Psychiatry Department of University Hospital Vall d'Hebron in Barcelona (Spain) using these three groups, NS, PS and CIPD, was performed. All patients were evaluated with the PRISM interview. ANOVA, Chi-square tests and multivariate multinomial regression analysis were used to perform statistical analyses. Seven patients with a primary psychotic disorder were discharged.Forty-six patients (32.1%) did not report any psychotic symptoms. Ninety-seven patients (67.9%) presented with a history of any cocaine-induced psychotic symptom and were considered as the cocaine-induced psychotic (CIP) group.Among them, 39 (27.3%) were included in the PS group, and 58 (40.6%) were included in the CIPD group. A history of imprisonment was found significantly more frequently in the PS than the NS group. The distribution of age at onset of dependence, lifetime cannabis abuse or dependence and imprisonment were significantly different between the NS and CIPD groups. We conclude that in cocaine-dependent patients, clinicians should be advised about the risk of development of psychotic symptoms. The presence of some psychotic symptoms could increase the potential risks of disturbing behaviours.

show abstract

“…Psychiatric disorders were diagnosed using the PRISM questionnaire, widely accepted for its reliability and validity in assessing substance-consuming subjects (Hasin et al, 1996;Torrens et al, 2004) so that we consider the present study to have good internal validity. However, the PRISM only considers two Axis II diagnostic categories (antisocial and borderline disorders).…”

Section: Discussionmentioning

confidence: 99%

Comorbilidad psiquiátrica en jóvenes-adultos consumidores de cannabis

Cuenca‐Royo¹,

Torrens

Sánchez-Niubò

et al. 2013

Adicciones

Self Cite

View full text Add to dashboard Cite

Resumen AbstractThis cross-sectional study aims to determine lifetime prevalence of psychiatric disorders (including substance use disorders, -SUD and other non substance use disorders, -Non-SUD) among 289 young (18-30 years) regular cannabis users, during the last year, in non-clinical settings in Barcelona. The Spanish version of the Psychiatric Interview for Substance and Mental Disorders (PRISM) was administered. Only 28% of the participants did not present any psychiatric disorder; while 65% had some SUD, the most common related to cannabis use (62%). Nearly 27% presented a non-SUD disorder. A younger age of initiation on alcohol use was associated with the presence of some SUD. Having consumed a greater number of "joints" in the last month was associated with the presence of both psychiatric disorders (SUD and non-SUD). While three quarters of subjects with non-SUD disorders had received some kind of treatment, only 28% of those with any SUD had received treatment. Given the low perception for need of treatment, there is a need for prevention strategies and to be able to offer therapies specifically tailored targeting young cannabis users.Key Words: cannabis, psychiatric disorders, treatment, PRISM.Este estudio transversal tiene como objetivo determinar la prevalencia vida de trastornos psiquiátricos (incluyendo los trastornos por uso de sustancias, -TUS y los otros trastornos no por uso de sustancias, -No-TUS) entre 289 jóvenes (18-30 años) consumidores regulares de cannabis durante el último año, reclutados fuera del entorno asistencial en Barcelona. Se administró la versión española de la Psychiatric Interview for Substance and Mental Disorders (PRISM). Sólo el 28% de los participantes no presentó ningún trastorno psiquiátrico, y el 65% tenía algún TUS, el más común relacionado con el cannabis (62%). Casi el 27% presentó trastornos no-TUS. Una edad de inicio más temprana en el consumo de alcohol se asoció con la presencia de algún TUS. Haber consumido un número mayor de "porros" en el último mes se asoció con la presencia de trastornos psiquiátricos (TUS y no-TUS).Mientras tres cuartas partes de los pacientes con trastornos no-TUS habían recibido algún tipo de tratamiento, sólo el 28% de las personas con cualquier TUS habían recibido tratamiento. Dada la baja percepción de necesidad de tratamiento, se hacen necesarias estrategias de prevención y poder ofrecer terapias adaptadas y dirigidas a los consumidores jóvenes de cannabis.

show abstract

Diagnosing Comorbid Psychiatric Disorders in Substance Abusers: Validity of the Spanish Versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV

Abstract: Using the LEAD procedure as a "gold standard," the authors conclude that the Spanish version of the PRISM seems to be a better instrument than the Spanish version of the SCID for diagnosing major depression and borderline personality disorders in substance abusers.

Cited by 197 publications

References 28 publications

The profile of psychiatric symptoms exacerbated by methamphetamine use

The profile of psychiatric symptoms exacerbated by methamphetamine use

Clinical differences between cocaine-induced psychotic disorder and psychotic symptoms in cocaine-dependent patients

Comorbilidad psiquiátrica en jóvenes-adultos consumidores de cannabis

Contact Info

Product

Resources

About